ADVERTISEMENT
Search

 

Press Releases

 

9

Mar

2022

Pharmacist groups call on Biden Administration to remove limits on prescribing COVID treatments

Modification to EUAs for Oral Antivirals Needed to Achieve Potential of “Test to Treat” Initiative

Author: Renee Kalu

WASHINGTON, D.C—Today, 14 pharmacy organizations urged the Biden Administration to remove barriers preventing pharmacists from ordering oral antivirals and expand patient access to the “Test to Treat” initiative announced last week during the State of the Union.

Comments (0)
Number of views (4153)
Article rating: No rating

7

Mar

2022

New Study: Medicare could save seniors billions by fixing Part D incentives

Author: Renee Kalu

WASHINGTON, DC and BESSEMER, AL—Plan sponsors and PBMs who manage prescription drug benefits under Medicare Part D are shifting costs and risks to America’s seniors and taxpayers by artificially inflating prescription drug costs at the pharmacy counter, according to a groundbreaking new study released today.

Comments (0)
Number of views (5155)
Article rating: No rating

3

Mar

2022

President Biden’s new "Test to Treat" initiative recognizes pharmacies, but barriers should be removed

Author: Renee Kalu

WASHINGTON, D.C.—The American Pharmacists Association (APhA) made the following statement today in response to the State of the Union address on Tuesday, March 1.

Comments (0)
Number of views (6171)
Article rating: No rating

23

Feb

2022

APhA2022 General Sessions topics and speakers announced

Sessions to focus on better care for patients and patient care through innovation

Author: Renee Kalu

WASHINGTON, DC—APhA2022, the American Pharmacists Association’s 2022 Annual Meeting & Exposition, has announced the speakers and topics for its two general sessions. APhA2022 will be an in-person event held March 18–21, 2022, at the Henry B. González Convention Center in San Antonio, TX.

Comments (0)
Number of views (4128)
Article rating: No rating

18

Feb

2022

APhA expresses disappointment at failed Federal Trade Commission vote to study PBMs’ anticompetitive business practices

APhA urges the Federal Trade Commission (FTC) to reach a consensus to not only study, but fix the broken PBM marketplace

Author: Renee Kalu

WASHINGTON, D.C.—The American Pharmacists Association (APhA) issued the following statement in response to the FTC’s stalemate 2-2 vote today, which would have supported study of the competitive impact of contractual provisions, reimbursement adjustments, and other PBM practices affecting drug prices, including those practices that may disadvantage independent or specialty pharmacies.

Comments (0)
Number of views (2824)
Article rating: No rating
RSS
First1112131416181920Last
ADVERTISEMENT